Our study identified 19/728 carriers (2.6%) of pathogenic HDR gene variants, including 15 truncating variants, of which 4 were in BRCA1 or BRCA2 (0.5%) and 4 were in BRIP1 or RAD51D, two other genes associated with high ovarian cancer risk. Here, BRCA2 is linked to ovarian cancer.